Treating Coronavirus Symptoms With Ibuprofen Is Probably Okay, Doctors Say

The clarification follows doubt about whether ibuprofen could worsen symptoms of COVID-19.

Richard B. Levine/Levine Roberts/Newscom/Zuma

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

Despite early warnings from France’s health minister and the World Health Organization, ibuprofen is still considered a safe treatment for symptoms of COVID-19, the disease caused by the coronavirus, such as fever and headache.

In a tweet on Saturday, French health minister Olivier Véran advised against the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen for treating COVID-19, suggesting that they could aggravate symptoms. The warning could stem from a recent study published in The Lancet Respiratory Medicine suggesting that anti-inflammatory medication could increase an individual’s susceptibility to infection, according to NPR.

After initially endorsing this recommendation and advising the use of acetaminophen instead, the WHO has reversed course, assuring the public that there is no clinical evidence to suggest that ibuprofen, sold under brand names including Motrin and Advil, worsens the symptoms of COVID-19.

As Dr. Angela Rogers, the chair of the intensive care unit’s COVID-19 task force at Stanford University Medical Center, tells NPR, acetaminophen, sold under the brand name Tylenol, is recommended for patients who are sick enough to go to the hospital because it is less likely to damage the kidneys than ibuprofen when taken long-term. But at high doses, acetaminophen can cause damage to the liver.

For now, doctors are indicating that any fever-reducer is an acceptable first-line treatment to symptoms of COVID-19.

DECEMBER IS MAKE OR BREAK

A full one-third of our annual fundraising comes in this month alone. That’s risky, because a strong December means our newsroom is on the beat and reporting at full strength—but a weak one means budget cuts and hard choices ahead.

The December 31 deadline is closing in fast. To reach our $400,000 goal, we need readers who’ve never given before to join the ranks of MoJo donors. And we need our steadfast supporters to give again—any amount today.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do.

That’s why we need you right now. Please chip in to help close the gap.

DECEMBER IS MAKE OR BREAK

A full one-third of our annual fundraising comes in this month alone. That’s risky, because a strong December means our newsroom is on the beat and reporting at full strength—but a weak one means budget cuts and hard choices ahead.

The December 31 deadline is closing in fast. To reach our $400,000 goal, we need readers who’ve never given before to join the ranks of MoJo donors. And we need our steadfast supporters to give again—any amount today.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do.

That’s why we need you right now. Please chip in to help close the gap.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate